Cargando…
ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations
BACKGROUND: A number of studies have investigated the roles of excision repair cross-complementation group 1 (ERCC1) gene rs3212986 polymorphisms as potential biomarkers in gastric cancer (GC). However, the results were inconsistent. Here, we performed a meta-analysis to explore ERCC1 rs3212986 poly...
Autores principales: | Tang, Weiwei, Wang, Hanjin, Wang, Yuemei, Wang, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741989/ https://www.ncbi.nlm.nih.gov/pubmed/29302191 http://dx.doi.org/10.2147/OTT.S148214 |
Ejemplares similares
-
Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014) -
Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso
por: Adico, Marc Donald Wilfried, et al.
Publicado: (2023) -
Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer
por: Boldrin, Elisa, et al.
Publicado: (2019) -
Rs3212986 polymorphism, a possible biomarker to predict smoking‐related lung cancer, alters DNA repair capacity via regulating ERCC1 expression
por: Yu, Tao, et al.
Publicado: (2018) -
The Relationship Between rs3212986C>A Polymorphism and Tumor Stage in Lung Cancer Patients
por: Anoushirvani, Ali Arash, et al.
Publicado: (2019)